-The Times of India A paragraph buried in the US-India joint statement, which talks of establishing an annual high-level Intellectual Property (IP) working group as part of the Trade Policy Forum, has made health activists across the world apprehensive that the Modi government might be bending to US pressure to change its patent laws. Several health policy experts and activists have issued statements urging India not to give in to US...

-DNA The Union government decision to decontrol prices of 108 drugs -- used to treat tuberculosis, AIDS, diabetes and heart ailments -- has jacked up their prices. In some cases, prices have seen an unbelievable rise. The price of Glivec, an anti-cancer tablet, for example, has risen from Rs 8,500 to Rs 1.08 lakh. Plavix, used to treat blood pressure and heart ailments, will cost Rs 1,615, against the earlier Rs 147. An...

-The Times of India MUMBAI: In the Indian pool of heart Patients, almost every second patient has high blood pressure, every fourth has diabetes and every fifth had plaque deposits in his/her arteries. This scientific picture of Indian heart diseases, at a time when prime minister Narendra Modi tours the US, comes from the American College of Cardiology's newly set up study centres across India. ACC is a not-for-profit medical association that...

-The New Indian Express NAGAPATTINAM: Ever tried traditional rice, the one that looks brownish-red? It may taste a bit different but it has immense health benefits. In fact, the biggest consumers of traditional rice breeds are private super specialty hospitals across major cities, which cater to dietary needs of Patients, predominantly diabetics. Besides health benefits, the breeds - Maapillai Samba, Kavuni, Garudan Samba, Thanga Samba and Samba Mosanam - are said to...

-The Indian Express Prime Minister Narendra Modi's US visit is likely to throw up highly contentious intellectual property rights issues. Indeed, for the last several years, US drug majors and their European counterparts have lobbied hard to demonise the Indian patent regime. But the government must continue to defend the law and stand its ground. Particularly since our own industrial moguls have caved in and are less vocal about their opposition...